Navigation Links
Vaccines developed, to treat melanoma in dogs

University Wisconsin, Madison School of Veterinary Medicine has developed cancer vaccine for the treatment of melanoma in dogs.

They have worked in collaboration with the oncologist from Arizona, California, and Michigan. This newly developed// anti-cancer vaccine is very efficient in preventing the death of the animal, but not all dogs with melanoma respond to this treatment. Ilene Kurzman, a researcher in the veterinary medical school's oncology section said that this will one day be an important step towards developing anti-cancer therapy for humans.

Melanoma, is a type of skin cancer which is very aggressive in dogs. Characteristic symptoms are seen but the mortality rate (75%) with the conventional treatment was very high. about 40 % of dogs with melanoma responded very well to the vaccine and in 12.5% the tumor completely disappeared.

The vaccine is developed from the dog melanoma cells that are treated so that they are no longer cancerous and grown in the laboratory.this DNA is inserted into the cells which secrete an immune stimulant. Then it is injected into the patient’s skin to stimulate the immune response, against the melanoma cells.

Dogs that received the vaccine lived twice as long as dogs that did not receive the vaccine. But further research has to be done to analyse the details of the vaccine completely.


'"/>




Page: 1

Related medicine news :

1. Producing Vaccines from genetically modified crops
2. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
3. New Anthrax Vaccines Will Take time
4. Success Of Preventable High-Risk HPV Infections With Vaccines May Vary
5. Health and Human Services stockpiles 20 million bird flu Vaccines
6. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
7. Oral Edible vaccine for Allergy Vaccines
8. South Africa May Start Manufacturing Bird Flu Vaccines
9. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
10. From Computers to Vaccines
11. India To Produce More Cost Effective Vaccines
Post Your Comments:
(Date:9/5/2008)...verweight or obese at age 45 , , FRIDAY,...erican adults will develop osteoarthritis of the k... obese in middle age, a new study says. , A pe...sed as his or her body-mass index (BMI) rose, acco...l Hill study. People who were of normal weight at ...
(Date:9/5/2008)...on Week,s Annual Destination to Feature VelaShape....RWEB) September 5, 2008 -- http://www.americanlas... Laser], the largest provider of laser hair remova...U.S., announces sponsorship of the STYLE360 show d... 7-10, serves as the alternative Fashion Week dest...
(Date:9/4/2008)...may be shortchanging their golden years by tapping...versity of Illinois expert who has studied the fed... More than three of every four Americans trim the...ming benefits early, a choice many might forego if...consequences, law professor Richard L. Kaplan says...
(Date:9/4/2008)...old-Out and Sustainable Packaging .../PRNewswire/ -- The latest innovations in raw,mate... sustainable,packaging will be on full display at ...ber 9, 10, 11 at the Jacob K. Javits Convention Ce...Pavilions at the event are sold-out and,sustainabl...
Breaking Medicine News(10 mins):Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:HBA Exhibit Floor Offers Global Resources to the Beauty and Personal Care Industry 2Health News:HBA Exhibit Floor Offers Global Resources to the Beauty and Personal Care Industry 3
...ted may be even costlier than you thought. The 24-...vide could be adversely affecting people's lives /...d in the journal Marriage and Family, those who re...ienced increased psychological distress and a decr...
...de are suffering from cancer. Virgin money life an... insurance policy exclusively to cater the needs o... cover "The big V" declares that it is 45% cheaper...programme. The incidence of cancer in UK is very...
...ruce Wilson, a Milwaukee Cardiologist, and Chief o... Health Care System is in dire need of a shot in t...er to the ills of prevailing healthcare systems, w...and inadequate support. Wilson, in an opinion writ...
...rs mostly could not balance its usage between offi...re disturbed by their boss for instructions and wo...th their family members which interferes with thei...the mobile phones and pagers ringing from their ho...
Other Medicine News:Health News:Is all this technology stressing you out? 2Health News:Cancer Cover Insurance “The Big V” Is Launched In U 2
(Date:9/4/2008)...tion for Targeted Therapies That Ensu...N BEACH, Calif., and AMSTERDAM, Netherlands, Sept....cular cancer diagnostics,today announced the laun...llows physicians to quantitatively determine the g...), progesterone receptor (PR) and Human Epidermal,...
(Date:9/3/2008)...Children Studied. Wrong,Conclusions Reached., NIX...rs for Disease,Control and Prevention (CDC) study ... MMR vaccine and autism. The National Autism Assoc...l the growing public concern over a,vaccine-autism...g design,and methodology., For years, parents hav...
(Date:9/3/2008)...ronically infected Hepatitis C,patients strongly c...n 2008, - Study is the first to show a statistic...fect of therapeutic Hepatitis C vaccination, - D...second generation, vaccine formulated with Interc... activation, VIENNA, Austria...
(Date:9/3/2008)...e/ -- Panacea Pharmaceuticals,Inc. today announce...ering,antibodies against human aspartyl (asparagin...ancer biomarker and therapeutic target. These anti...ssachusetts Institute of,Technology (MIT) and Pana...,for development of human cancer diagnostics and t...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2CDC Misses Target With Flawed MMR/Autism Study 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Jury Rules in Favor of Glycoproducts International Inc 20365 1Jury Rules in Favor of Glycoproducts International Inc 20365 2Photos 3A Los Angeles Non Profit Teams With US Troops Stationed in Baghdad and Buaytha in Bringing a 5 Year Old Blind Iraqi Girl Whose Father Stands 20360 1Photos 3A Los Angeles Non Profit Teams With US Troops Stationed in Baghdad and Buaytha in Bringing a 5 Year Old Blind Iraqi Girl Whose Father Stands 20360 2Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 1Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 2Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 3Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 4Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 5Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 6Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 7Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 8Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 9Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 10Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 11Researchers from 5 countries to test hygiene hypothesis with EU funding 20355 1Researchers from 5 countries to test hygiene hypothesis with EU funding 20355 2
...urne, Australia — 19 April 2007- Biota Holdi...g acting,neuraminidase inhibitor (LANI), CS8958, a...d effectiveness against the avian flu virus,H5N1; ...ceived ethics approval to commence comparable stud...Daiichi-Sankyo, overnight announced,that laborator...
...nnounces Positive Top-Line Phase III Results for,K... Seizures in,Paediatric Patients from One Month to... April 20, 2007 - UCB today announced,positive top...omized, multi-centre, placebo-controlled study eva...g; (levetiracetam) (20-50,mg/kg/day) as adjunctive...
Other Medicine Technology:LANI completes Phase I in Japan and to commence Phase I in UK 2LANI completes Phase I in Japan and to commence Phase I in UK 3LANI completes Phase I in Japan and to commence Phase I in UK 4UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 2UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 3UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 4UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 5
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: